当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析 - 现金流量表

新华医疗

(600587)

  

流通市值:83.05亿  总市值:83.05亿
流通股本:6.07亿   总股本:6.07亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,104,694,559.449,219,926,033.96,543,184,025.824,344,432,565.17
  收到的税费返还3,226,715.9812,764,005.932,761,465.63833,600.1
  收到其他与经营活动有关的现金138,562,696.79256,022,825.72217,994,965.2153,122,012.44
  经营活动现金流入小计2,246,483,972.219,488,712,865.556,763,940,456.654,498,388,177.71
  购买商品、接受劳务支付的现金1,245,554,948.575,790,923,266.024,258,430,728.822,722,941,294.84
  支付给职工以及为职工支付的现金511,183,997.341,706,551,621.451,280,425,889.34876,189,693.92
  支付的各项税费140,936,880.86418,591,288.93344,602,000.05222,863,987.83
  支付其他与经营活动有关的现金281,145,586.89872,009,768.75660,818,055.62433,641,951.27
  经营活动现金流出小计2,178,821,413.668,788,075,945.156,544,276,673.834,255,636,927.86
  经营活动产生的现金流量净额67,662,558.55700,636,920.4219,663,782.82242,751,249.85
二、投资活动产生的现金流量:
  收回投资收到的现金2,324,724.0228,705,032.4612,405,032.461,000,000
  取得投资收益收到的现金-89,336,819.736,547,734.086,460,245.86
  处置固定资产、无形资产和其他长期资产收回的现金净额4,6301,035,945.751,020,035.751,003,018.85
  处置子公司及其他营业单位收到的现金净额-103,563,260.5199,870,479.7599,870,479.75
  投资活动现金流入小计2,329,354.02222,641,058.45119,843,282.04108,333,744.46
  购建固定资产、无形资产和其他长期资产支付的现金18,830,367.55381,549,258.53298,226,154.22244,852,210.3
  投资支付的现金-23,944,877.4223,944,877.4216,944,877.42
  支付其他与投资活动有关的现金708,000,000---
  投资活动现金流出小计726,830,367.55405,494,135.95322,171,031.64261,797,087.72
  投资活动产生的现金流量净额-724,501,013.53-182,853,077.5-202,327,749.6-153,463,343.26
三、筹资活动产生的现金流量:
  取得借款收到的现金301,000,0001,194,730,000935,150,000657,500,000
  收到其他与筹资活动有关的现金-22,809,962.7111,000,00011,000,000
  筹资活动现金流入小计301,000,0001,217,539,962.71946,150,000668,500,000
  偿还债务支付的现金323,283,990.521,149,833,684.23893,137,723.08592,229,500
  分配股利、利润或偿付利息支付的现金13,582,153.7352,942,702.7198,794,969.2128,776,015.32
  其中:子公司支付给少数股东的股利、利润4,742,83610,324,0007,484,0006,292,900
  支付其他与筹资活动有关的现金5,207,847.4935,082,06424,141,009.2214,464,963.38
  筹资活动现金流出小计342,073,991.711,537,858,450.931,116,073,701.51635,470,478.7
  筹资活动产生的现金流量净额-41,073,991.71-320,318,488.22-169,923,701.5133,029,521.3
四、汇率变动对现金及现金等价物的影响-3,483,751.12-371,650.4337,491.42-232,779.97
五、现金及现金等价物净增加额-701,396,197.81197,093,704.25-152,550,176.87122,084,647.92
  加:期初现金及现金等价物余额2,966,856,645.272,769,762,941.022,769,762,941.022,769,762,941.02
  期末现金及现金等价物余额2,265,460,447.462,966,856,645.272,617,212,764.152,891,847,588.94
补充资料:
  净利润-528,134,579.86-390,391,575.67
  资产减值准备-78,503,721.65-14,253,517.71
  固定资产和投资性房地产折旧-192,071,005.02-80,569,078.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-192,071,005.02-80,569,078.67
  无形资产摊销-20,694,272.32-9,607,080.96
  长期待摊费用摊销-41,487,228.34-20,812,624.28
  处置固定资产、无形资产和其他长期资产的损失-993,363.98-837,997.31
  固定资产报废损失-1,755,394.88-1,746,428.7
  财务费用-41,777,624.07-2,162,228.93
  投资损失--39,100,637.21--3,532,052.54
  递延所得税--6,891,990.48-10,758,322.35
  其中:递延所得税资产减少--9,541,473.83-7,675,641.42
    递延所得税负债增加-2,649,483.35-3,082,680.93
  存货的减少-398,244,280.46-260,029,568.79
  经营性应收项目的减少-16,374,680.42--20,700,376.98
  经营性应付项目的增加--639,184,402.26--543,159,247.62
  现金的期末余额-2,966,856,645.27-2,891,847,588.94
  减:现金的期初余额-2,769,762,941.02-2,769,762,941.02
  现金及现金等价物的净增加额-197,093,704.25-122,084,647.92
公告日期2026-04-302026-04-302025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑